While upregulated JMJD2B expression has been implicated in the pathogenesis of non-small cell lung carcinoma cells [15] and pulmonary hypertension [16], literature is scarce in the fields of asthma and COPD. Here, KDM4B is linked to non-small cell lung carcinoma.